After several news outlets reported last month that EHR vendor Allscripts could be looking for a potential buyer, the company finally made public last week that it is, in fact, considering a sale. Company executives, however, have also made it known that they are looking into other alternatives, as well.
Despite the fact that a buyer hasn’t been announced and that Allscripts could keep from changing hands, third-quarter revenue still dropped, and the company’s stock price is approximately half of what it was last year. This is largely attributed to the fact that customers are doubtful about the company’s future.
The uncertainty has stopped several healthcare providers from signing with Allscripts – and it has led many more to jump ship. In fact, many small practice doctors started transitioning away from Allscripts last month after the company communicated that it would be phasing out its MyWay EHR, a product geared toward individual practices with three physicians or fewer. Continue reading at Health Technology Review…
Posted on October 06, 2021 by Pablo Bullian
Medical Web Experts Security Bulletin: October 2021
Walgreens’ Poor Security Measures Exposed Patient Data and Covid-19 Test Results Patients who got a Covid-19 test at Walgreens, possibly as far back as July 2020, were vulnerable to data…Read more